Sagimet Biosciences Inc. Liabilities, Current in USD from Q4 2022 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: Sagimet Biosciences Inc. quarterly Liabilities, Current history and growth rate from Q4 2022 to Q3 2025.
Sagimet Biosciences Inc. Liabilities, Current for the quarter ending September 30, 2025 was $9.15M.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Growth (%)

Sagimet Biosciences Inc. Quarterly Liabilities, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2025	$9.15M			Sep 30, 2025	10-Q	2025-11-13
Q2 2025	$7.25M			Jun 30, 2025	10-Q	2025-08-13
Q4 2024	$4.45M	-$1.2M	-21.2%	Dec 31, 2024	10-Q	2025-11-13
Q4 2023	$5.65M	+$375K	+7.1%	Dec 31, 2023	10-K	2025-03-12
Q3 2023	$5.05M			Sep 30, 2023	10-Q	2023-11-13
Q2 2023	$5.29M			Jun 30, 2023	10-Q	2023-08-21
Q4 2022	$5.28M			Dec 31, 2022	10-K	2024-03-25

* An asterisk sign (*) next to the value indicates that the value is likely invalid.